SOD1 and myeloid sarcoma: The next study by Miller et al. [48] was conducted in patients with depressive and non-depressive MS and had the same aim as the previous two: to compare the effect of WBC on the plasma TAS and the activity of selected anti-oxidant enzymes in the erythrocytes (the SOD and CAT).